Volume | 187,618 |
|
|||||
News | - | ||||||
Day High | 0.60 | Low High |
|||||
Day Low | 0.56 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
VBI Vaccines Inc | VBIV | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.5914 | 0.56 | 0.60 | 0.574 | 0.5994 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
533 | 187,618 | $ 0.5766991 | $ 108,199 | - | 0.45 - 3.47 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:11:52 | 17 | $ 0.588 | USD |
VBI Vaccines Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
13.5M | 23.69M | - | 8.68M | -93.84M | -3.96 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
VBI Vaccines News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VBIV Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.64 | 0.658 | 0.56 | 0.6073944 | 162,823 | -0.0526 | -8.22% |
1 Month | 0.60 | 1.35 | 0.55 | 0.6859052 | 1,143,484 | -0.0126 | -2.10% |
3 Months | 0.735 | 1.35 | 0.53 | 0.6682671 | 471,440 | -0.1476 | -20.08% |
6 Months | 0.50 | 1.35 | 0.4884 | 0.6577062 | 282,914 | 0.0874 | 17.48% |
1 Year | 2.72 | 3.47 | 0.45 | 1.66 | 506,670 | -2.13 | -78.40% |
3 Years | 88.80 | 129.30 | 0.45 | 55.14 | 1,576,946 | -88.21 | -99.34% |
5 Years | 58.50 | 217.20 | 0.45 | 74.60 | 3,525,680 | -57.91 | -99.00% |
VBI Vaccines Description
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology. |